Editorial: Regulatory polymorphisms in key candidate genes for disease susceptibility and drug response: A mandate for valid genetic biomarkers

Expert Review of Molecular Diagnostics

Volumn 10, Issue 1, 2010, Pages 9-11

  Sadee, Wolfgang ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AMINO ACID SEQUENCE; DISEASE PREDISPOSITION; DRUG RESPONSE; EDITORIAL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC REGULATION; GENETIC VARIABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; ART; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; METHODOLOGY; PHARMACOGENETICS; REGULATORY SEQUENCE;

ANIMALS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PORTRAITS AS TOPIC; REGULATORY ELEMENTS, TRANSCRIPTIONAL;

EID: 74749106489     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.09.72     Document Type: Editorial

References (11)

1. Hardy J, Singleton A. Genome-wide association studies and human disease. N. Engl. J. Med. 360, 1759-1768 (2009).
2. Wray GA. The evolutionary significance of cis-regulatory mutations. Nat. Rev. Genet. 8, 206-216 (2007).
3. Johnson AD, Wang D, Sadee W. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Pharmacol. Ther. 106, 19-38 (2005).
4. Johnson, AD, Zhang Y, Papp AC et al. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenet. Genomics 18, 781-791 (2008).
5. Zhang Y, Bertolino A, Fazio L et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl Acad. Sci. USA 104, 20552-20557 (2007).
6. Lim JE, Pinsonneault J, Sadee W, Saffen D. Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol. Psychiatry 12, 491-501 (2007).
7. Wang D, Chen H, Momary KM, Cavallari LH, Johnson JA, Sadee W. Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement. Blood 112, 1013-1021 (2008).
8. Johnson AD, Gong Y, Wang D et al. Promoter polymorphisms in ACE (angiotensin-I converting enzyme) associated with clinical outcomes in hypertension. Clin. Pharmacol. Ther. 85, 336-344 (2009).
9. Risch N, Herrell R, Lehner T et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a metaanalysis. J. Am. Med. Assoc. 301, 2462-2471 (2009).
10. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531 (1996).
11. Lim J-E, Papp A, Pinsonneault J, Sadee W, Saffen D. Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol. Psych. 11, 649-662 (2006).